Patients/Healthcare Providers

We are pleased to announce the addition of two new conditions to our TreatGx medication decision support system. Alzheimer’s Disease and Insomnia can now be accessed by all TreatGx users.   The Alzheimer’s algorithm provides treatment options for adults with mild, moderate, or severe Alzheimer’s disease, and includes guidance on medication titration and switching. Treatment options and dosing are based on the most up-to-date...

The GenXys algorithm for Smoking Cessation has been updated and the new version is available to all TreatGx users.  To continue to provide effective medication options and strategies for smoking cessation, we reviewed and incorporated information from recent guidelines and papers.  These include the 2018 NICE guideline [1] and the 2018 American College of Cardiology expert consensus decision pathway [2].  We also included evidence from a recent Cochrane review on the use of different doses, durations...

All TreatGx users now have access to the updated Epilepsy and Rheumatoid Arthritis treatment algorithms. The Epilepsy update includes comprehensive treatment recommendations for specific types of epilepsy from the latest international guidelines, including the National Institute for Health and Care Excellence [1], Scottish Intercollegiate Guidelines Network...

All TreatGx users have access to the updated Bipolar I Disorder treatment algorithm and the Acute Exacerbation of COPD treatment algorithm. These comprehensive updates include many exciting enhancements that will help health care providers select the safest and most effective medications with their patients. All...